| Title: |
480TiP Phase 3, randomised, open-label study of durvalumab (MEDI4736) in combination with tremelimumab versus platinum-based chemotherapy in first-line treatment of patients with advanced or metastatic NSCLC: NEPTUNE |
| Authors: |
Mok, T.; Schmid, P.; Arén, O.; Arrieta, O.; Gottfried, M.; Jazieh, A.R.; Ramlau, R.; Timcheva, C.; Martin, C.; Zhao, L.; McIntosh, S. |
| Source: |
Annals of Oncology ; volume 26, page ix125 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2015 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/annonc/mdv532.64 |
| Availability: |
http://dx.doi.org/10.1093/annonc/mdv532.64; https://api.elsevier.com/content/article/PII:S0923753419465836?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753419465836?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.8F64D1F9 |
| Database: |
BASE |